Tigeforte

TIGEFORTE is a prescription glycylcycline antibiotic containing Tigecycline (50 mg/Vial) in a lyophilized (freeze-dried) form. It operates by inhibiting bacterial protein synthesis, making it effective against a broad spectrum of susceptible microorganisms, including some drug-resistant strains. Clinical indications primarily encompass the treatment of complicated skin and skin structure infections, complicated intra-abdominal infections, and community-acquired bacterial pneumonia. Because it is a potent, single-use antibiotic, TIGEFORTE must be reconstituted and administered exclusively via slow intravenous infusion under careful clinical supervision within a hospital setting to avoid serious adverse reactions or resistance.